Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

[1]  Chronic Disease Division.  Cancer facts and figures , 2010 .

[2]  T. Vlaykova,et al.  Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer , 2009, Journal of gastroenterology and hepatology.

[3]  A. Harris,et al.  Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer. , 2009, Pathology, research and practice.

[4]  P. McDonald,et al.  Angiogenesis and hypoxic factors in colorectal cancer. , 2008, Pathology, research and practice.

[5]  R. Agarwal,et al.  Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. , 2008, Cancer research.

[6]  David B Seligson,et al.  Hypoxia-Inducible Factor 1α in Clear Cell Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[7]  G. Gao,et al.  Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis , 2007, Molecular Cancer Therapeutics.

[8]  M. Ohh,et al.  The role of hypoxia-inducible factors in cancer , 2007, Cellular and Molecular Life Sciences.

[9]  M. van Engeland,et al.  Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[10]  Emmanuel Chamorey,et al.  HIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome , 2007 .

[11]  A. C. Williams,et al.  Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia , 2007, Nature Cell Biology.

[12]  R. Jain,et al.  Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. , 2006, Seminars in oncology.

[13]  D. Cunningham,et al.  Emerging therapies for rectal cancer , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[14]  M. Piris,et al.  The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. , 2006, Cancer cell.

[15]  M. Gazouli,et al.  Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer , 2006, International Journal of Colorectal Disease.

[16]  M. Bibby,et al.  Expression of HIF-1alpha and Glut-1 in human bladder cancer. , 2005, Oncology reports.

[17]  H. Mackay,et al.  A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.

[18]  W. Sly,et al.  Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa. , 2005, World journal of gastroenterology.

[19]  A. Lazaris,et al.  Evaluation of hypoxia‐inducible factor 1α overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma , 2005, BJU international.

[20]  M. Tachibana,et al.  Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients , 2004, Clinical Cancer Research.

[21]  D. Roter.  Patient-centered communication , 2004, BMJ : British Medical Journal.

[22]  M. Wood,et al.  Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors , 2004, Journal of cellular biochemistry.

[23]  Z. Kmietowicz.  British cancer death rates fell by 12% between 1972 and 2002 , 2004, BMJ : British Medical Journal.

[24]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[25]  Yu-feng Yuan,et al.  [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.

[26]  Y. Nakajima,et al.  Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. , 2003, Anticancer research.

[27]  K. Chayama,et al.  Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinoma , 2003, International journal of cancer.

[28]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[29]  S. Kumar,et al.  Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis , 2003, British Journal of Cancer.

[30]  He-sheng Luo,et al.  Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. , 2003, World journal of gastroenterology.

[31]  A. Harris,et al.  Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[32]  Marian Taylor,et al.  Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer , 2002 .

[33]  A. Harris,et al.  Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. , 2001, Anticancer research.

[34]  G. Semenza.  Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease , 2001, Pediatric Research.

[35]  P. Carmeliet,et al.  Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.

[36]  A. Harris,et al.  Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. , 2000, Cancer research.

[37]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.

[38]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[39]  J. Weyler,et al.  Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer , 1999, British Journal of Cancer.

[40]  S. Hong,et al.  Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence , 1998, Oncology.

[41]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[42]  L. Påhlman,et al.  Improved survival in patients with rectal cancer: a population‐based register study , 1998, The British journal of surgery.

[43]  M. Gassmann,et al.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.

[44]  B. Ebert,et al.  Oxygen regulated gene expression: erythropoietin as a model system. , 1997, Kidney international.

[45]  Y. Maehara,et al.  Microvessel quantification and its possible relation with liver metastasis in colorectal cancer , 1996, Cancer.

[46]  G. Viale,et al.  Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. , 1995, Cancer research.

[47]  L. Påhlman,et al.  Prognostic predictors in colorectal cancer , 1994, Diseases of the colon and rectum.

[48]  Emmanuel Chamorey,et al.  HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. , 2007, International journal of cancer.

[49]  A. C. Williams,et al.  Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. , 2007, Nature cell biology.

[50]  Jie Chen,et al.  Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. , 2006, Clinical colorectal cancer.

[51]  D. Wan,et al.  [Correlation of tumor microvessel density to metastasis and recurrence of rectal cancer]. , 2004, Ai zheng = Aizheng = Chinese journal of cancer.

[52]  M. Tachibana,et al.  Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  K. Chayama,et al.  Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. , 2003, International journal of cancer.

[54]  A. Harris,et al.  Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. , 2002, Cancer research.

[55]  A. Harris,et al.  The HIF pathway: implications for patterns of gene expression in cancer. , 2001, Novartis Foundation symposium.

[56]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. , 2000, The American journal of pathology.